Advertisement
Screener

PRECISION OPTICS CORPORATION, INC. (POCI) Business Acquisition, Pro Forma Revenue

2.3 / 5 stars · 48/103 Roast Me

PRECISION OPTICS CORPORATION, INC. Business Acquisition, Pro Forma Revenue

PRECISION OPTICS CORPORATION, INC. (POCI) reported Business Acquisition, Pro Forma Revenue of $5.05 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.

Discontinued › Income Statement › Other Income

us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2023-09-28

  • PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma revenue for the quarter ending 2023-03-31 was $5.05M, a 8.53% increase year-over-year.
  • PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma revenue for the quarter ending 2022-12-31 was $5.89M, a 51.06% increase year-over-year.
  • PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma revenue for the quarter ending 2022-09-30 was $5.09M, a 34.51% increase year-over-year.
  • PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma revenue for the quarter ending 2022-06-30 was $4.79M, a 18.97% increase year-over-year.
  • PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma revenue for fiscal 2022 was $17.12M, a 9.57% increase from fiscal 2021.
  • PRECISION OPTICS CORPORATION, INC. business acquisition, pro forma revenue for fiscal 2021 was $15.63M.
Period endBusiness Acquisition, Pro Forma Revenue 3 monthBusiness Acquisition, Pro Forma Revenue 6 monthBusiness Acquisition, Pro Forma Revenue 9 monthBusiness Acquisition, Pro Forma Revenue 12 month
2023-03-31$5.05M
10-Q · filed 2023-05-15
$10.94M
derived: sum of 2 quarters · filed 2023-05-15
$16.02M
10-Q · filed 2023-05-15
$20.81M
derived: sum of 4 quarters · filed 2023-09-28
2022-12-31$5.89M
10-Q · filed 2023-02-14
$10.97M
10-Q · filed 2023-02-14
$15.77M
derived: sum of 3 quarters · filed 2023-09-28
$20.42M
derived: sum of 4 quarters · filed 2023-09-28
2022-09-30$5.09M
10-Q · filed 2022-11-14
$9.88M
derived: sum of 2 quarters · filed 2023-09-28
$14.53M
derived: sum of 3 quarters · filed 2023-09-28
$18.43M
derived: sum of 4 quarters · filed 2023-09-28
2022-06-30$4.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28
$9.44M
derived: sum of 2 quarters · filed 2023-09-28
$13.34M
derived: sum of 3 quarters · filed 2023-09-28
$17.12M
10-K · filed 2023-09-28
2022-03-31$4.65M
10-Q · filed 2023-05-15
$8.55M
derived: sum of 2 quarters · filed 2023-05-15
$12.33M
10-Q · filed 2023-05-15
$16.36M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$3.90M
10-Q · filed 2023-02-14
$7.68M
10-Q · filed 2023-02-14
$11.71M
derived: sum of 3 quarters · filed 2023-02-14
$15.31M
derived: sum of 4 quarters · filed 2023-02-14
2021-09-30$3.78M
10-Q · filed 2022-11-14
$7.81M
derived: sum of 2 quarters · filed 2022-11-14
$11.41M
derived: sum of 3 quarters · filed 2022-11-14
$15.49M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$4.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27
$7.63M
derived: sum of 2 quarters · filed 2022-09-27
$11.70M
derived: sum of 3 quarters · filed 2022-09-27
$15.63M
10-K · filed 2022-09-27
2021-03-31$3.60M
10-Q · filed 2022-05-16
$7.68M
derived: sum of 2 quarters · filed 2022-05-16
$11.60M
10-Q · filed 2022-05-16
2020-12-31$4.07M
10-Q · filed 2022-02-14
$8.00M
10-Q · filed 2022-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outset Medical, Inc. (OM)United States$0.059B-1.09
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
Streamex Corp. (STEX)United States$0.089B-0.19
IRIDEX CORP (IRIX)United States$0.011B
Nexalin Technology, Inc. (NXL)United States$0.094B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Neuraxis, INC (NRXS)United States$0.097B
Nuwellis, Inc. (NUWE)United States$0.003B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B